194 related articles for article (PubMed ID: 30248327)
21. Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism.
Smith KJ; Murray IA; Tanos R; Tellew J; Boitano AE; Bisson WH; Kolluri SK; Cooke MP; Perdew GH
J Pharmacol Exp Ther; 2011 Jul; 338(1):318-27. PubMed ID: 21493753
[TBL] [Abstract][Full Text] [Related]
22. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology.
Esser C; Rannug A
Pharmacol Rev; 2015; 67(2):259-79. PubMed ID: 25657351
[TBL] [Abstract][Full Text] [Related]
23. Novel roles for AhR and ARNT in the regulation of alcohol dehydrogenases in human hepatic cells.
Attignon EA; Leblanc AF; Le-Grand B; Duval C; Aggerbeck M; Rouach H; Blanc EB
Arch Toxicol; 2017 Jan; 91(1):313-324. PubMed ID: 27055685
[TBL] [Abstract][Full Text] [Related]
24. The effect of aryl hydrocarbon receptor ligands on the expression of polymerase (DNA directed) kappa (Polκ), polymerase RNA II (DNA directed) polypeptide A (PolR2a), CYP1B1 and CYP1A1 genes in rat liver.
Brauze D; Rawłuszko AA
Environ Toxicol Pharmacol; 2012 Nov; 34(3):819-25. PubMed ID: 23026235
[TBL] [Abstract][Full Text] [Related]
25. Activation of the aryl hydrocarbon receptor by the calcium/calmodulin-dependent protein kinase kinase inhibitor 7-oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid (STO-609).
Monteiro P; Gilot D; Langouet S; Fardel O
Drug Metab Dispos; 2008 Dec; 36(12):2556-63. PubMed ID: 18755850
[TBL] [Abstract][Full Text] [Related]
26. In vivo effects of the pure aryl hydrocarbon receptor antagonist GNF-351 after oral administration are limited to the gastrointestinal tract.
Fang ZZ; Krausz KW; Nagaoka K; Tanaka N; Gowda K; Amin SG; Perdew GH; Gonzalez FJ
Br J Pharmacol; 2014 Apr; 171(7):1735-46. PubMed ID: 24417285
[TBL] [Abstract][Full Text] [Related]
27. Molecular and developmental effects of exposure to pyrene in the early life-stages of Cyprinodon variegatus.
Hendon LA; Carlson EA; Manning S; Brouwer M
Comp Biochem Physiol C Toxicol Pharmacol; 2008 Mar; 147(2):205-15. PubMed ID: 17962083
[TBL] [Abstract][Full Text] [Related]
28. Alternation of extracellular matrix remodeling and apoptosis by activation of the aryl hydrocarbon receptor pathway in human periodontal ligament cells.
Tomokiyo A; Maeda H; Fujii S; Monnouchi S; Wada N; Hori K; Koori K; Yamamoto N; Teramatsu Y; Akamine A
J Cell Biochem; 2012 Oct; 113(10):3093-103. PubMed ID: 22581694
[TBL] [Abstract][Full Text] [Related]
29. Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor.
Kim SH; Henry EC; Kim DK; Kim YH; Shin KJ; Han MS; Lee TG; Kang JK; Gasiewicz TA; Ryu SH; Suh PG
Mol Pharmacol; 2006 Jun; 69(6):1871-8. PubMed ID: 16540597
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the aromatic hydrocarbon receptor gene and its expression in Atlantic tomcod.
Roy NK; Wirgin I
Arch Biochem Biophys; 1997 Aug; 344(2):373-86. PubMed ID: 9264552
[TBL] [Abstract][Full Text] [Related]
31. Genotoxic polycyclic aromatic hydrocarbon ortho-quinones generated by aldo-keto reductases induce CYP1A1 via nuclear translocation of the aryl hydrocarbon receptor.
Burczynski ME; Penning TM
Cancer Res; 2000 Feb; 60(4):908-15. PubMed ID: 10706104
[TBL] [Abstract][Full Text] [Related]
32. Ligand promiscuity of aryl hydrocarbon receptor agonists and antagonists revealed by site-directed mutagenesis.
Soshilov AA; Denison MS
Mol Cell Biol; 2014 May; 34(9):1707-19. PubMed ID: 24591650
[TBL] [Abstract][Full Text] [Related]
33. Zebrafish cardiotoxicity: the effects of CYP1A inhibition and AHR2 knockdown following exposure to weak aryl hydrocarbon receptor agonists.
Brown DR; Clark BW; Garner LV; Di Giulio RT
Environ Sci Pollut Res Int; 2015 Jun; 22(11):8329-38. PubMed ID: 25532870
[TBL] [Abstract][Full Text] [Related]
34. 2,3,7,8-Tetrachlorodibenzo-p-dioxin's suppression of 1-nitropyrene-induced p53 expression is mediated by cytochrome P450 1A1.
Su JG; Huang MC; Chen FY
Chem Res Toxicol; 2011 Dec; 24(12):2167-75. PubMed ID: 22044530
[TBL] [Abstract][Full Text] [Related]
35. Binding studies using Pichia pastoris expressed human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins.
Zheng Y; Xie J; Huang X; Dong J; Park MS; Chan WK
Protein Expr Purif; 2016 Jun; 122():72-81. PubMed ID: 26923060
[TBL] [Abstract][Full Text] [Related]
36. Prediction and validation of apoptosis through cytochrome P450 activation by benzo[a]pyrene.
Das DN; Panda PK; Mukhopadhyay S; Sinha N; Mallick B; Behera B; Maiti TK; Bhutia SK
Chem Biol Interact; 2014 Feb; 208():8-17. PubMed ID: 24239969
[TBL] [Abstract][Full Text] [Related]
37. Cooperation of structurally different aryl hydrocarbon receptor agonists and β-catenin in the regulation of CYP1A expression.
Vaas S; Kreft L; Schwarz M; Braeuning A
Toxicology; 2014 Nov; 325():31-41. PubMed ID: 25174530
[TBL] [Abstract][Full Text] [Related]
38. Reduction of CC-chemokine ligand 5 by aryl hydrocarbon receptor ligands.
Morino-Koga S; Uchi H; Tsuji G; Takahara M; Kajiwara J; Hirata T; Furue M
J Dermatol Sci; 2013 Oct; 72(1):9-15. PubMed ID: 23810773
[TBL] [Abstract][Full Text] [Related]
39. TCDD and omeprazole prime platelets through the aryl hydrocarbon receptor (AhR) non-genomic pathway.
Pombo M; Lamé MW; Walker NJ; Huynh DH; Tablin F
Toxicol Lett; 2015 May; 235(1):28-36. PubMed ID: 25797602
[TBL] [Abstract][Full Text] [Related]
40. Structural Insights into the Activation of Human Aryl Hydrocarbon Receptor by the Environmental Contaminant Benzo[a]pyrene and Structurally Related Compounds.
Kwong HS; Paloni M; Grandvuillemin L; Sirounian S; Ancelin A; Lai-Kee-Him J; Grimaldi M; Carivenc C; Lancey C; Ragan TJ; Hesketh EL; Balaguer P; Barducci A; Gruszczyk J; Bourguet W
J Mol Biol; 2024 Feb; 436(3):168411. PubMed ID: 38135181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
